These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2791187)

  • 1. A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
    Storm G; van Hoesel QG; de Groot G; Kop W; Steerenberg PA; Hillen FC
    Cancer Chemother Pharmacol; 1989; 24(6):341-8. PubMed ID: 2791187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.
    van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC
    Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumor.
    Storm G; Van Gessel HJ; Steerenberg PA; Speth PA; Roerdink FH; Regts J; Van Veen M; De Jong WH
    Cancer Drug Deliv; 1987; 4(2):89-104. PubMed ID: 3427554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
    Steerenberg PA; Storm G; de Groot G; Claessen A; Bergers JJ; Franken MA; van Hoesel QG; Wubs KL; de Jong WH
    Cancer Chemother Pharmacol; 1988; 21(4):299-307. PubMed ID: 3370737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of doxorubicin encapsulated in poly(ethylene glycol)-coated liposomes.
    Hosoda J; Unezaki S; Maruyama K; Tsuchiya S; Iwatsuru M
    Biol Pharm Bull; 1995 Sep; 18(9):1234-7. PubMed ID: 8845812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations.
    Storm G; Steerenberg PA; Van Borssum Waalkes M; Crommelin DJ
    J Drug Target; 1996; 4(4):255-64. PubMed ID: 9010815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect, cardiotoxicity, and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing LOU/M/WSL rat.
    van Hoesel QG; Steerenberg PA; Vos JG; Hillen FC; Dormans JA
    J Natl Cancer Inst; 1984 May; 72(5):1141-50. PubMed ID: 6585590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T
    Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations.
    de Wildt DJ; de Jong Y; Hillen FC; Steerenberg PA; van Hoesel QG
    J Pharmacol Exp Ther; 1985 Oct; 235(1):234-40. PubMed ID: 4045723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio.
    Roque MC; da Silva CD; Lempek MR; Cassali GD; de Barros ALB; Melo MM; Oliveira MC
    Biomed Pharmacother; 2021 Dec; 144():112307. PubMed ID: 34653762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II on the antitumor activity and cardiotoxicity of doxorubicin.
    Monti E; Paracchini L; Piccinini F; Rossi C; Formelli F
    Cancer Lett; 1990 Apr; 50(1):79-85. PubMed ID: 2353985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
    Arnold RD; Mager DE; Slack JE; Straubinger RM
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8856-65. PubMed ID: 16361575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
    Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
    Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome.
    Junping W; Maitani Y; Takayama K; Nagai T
    Int J Pharm; 2000 Aug; 203(1-2):61-9. PubMed ID: 10967428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior.
    Goren D; Gabizon A; Barenholz Y
    Biochim Biophys Acta; 1990 Nov; 1029(2):285-94. PubMed ID: 2245212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
    van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
    J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study.
    Gabizon A; Peretz T; Sulkes A; Amselem S; Ben-Yosef R; Ben-Baruch N; Catane R; Biran S; Barenholz Y
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1795-803. PubMed ID: 2632261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.